PODCAST · science
The Onco'Zine Brief
by Peter Hofland
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit). If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866. Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
Episodes
-
COVID-19 and the Impact of Cryopreservation on Hematopoietic Cell Grafts
In this episode of The Onco’Zine Brief Peter Hofland talks with Stephen Spellman. Stephen Spellman is Vice President and Senior Scientific Director at Be The Match and the Center for International Blood & Marrow Transplant Research (CIBMTR). Hofland and Spellman talk about the outcomes of a study...
-
SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer.
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Ely Benaim, MD, the Chief Medical Officer and Executive Vice President Development at SonALAsense and Mark De Souza, Ph.D, President and Chief Executive Officer of SonALAsense. SonALAsense was founded to create hope in the face of...
-
Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Jeffery Auletta, MD is Senior Vice President, Patient Outcomes and Experience, National Marrow Donor Program® (NMDP)/Be The Match®. Be The Match® is a global leader in bone marrow transplantation. The organization conducts research...
-
Developing a New Standard of Care: Cancer Treatment with Photoimmunotherapy
In a new episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia. Hofland and Cognetti talk about head and neck cancer and a novel treatment approach…
more -
Highlights from ASH: Conversations with Christopher Heery and Srdan Verstovsek
In this episode of The Onco'Zine Brief, Peter Hofland talks with two experts about their research and the impact the outcomes from these studies may have on the treatment of patients diagnosed with cancer. First, Hofland talks with Christopher Heery, MD. Dr Heery is a board-certified medical...
-
A Fantastic Voyage: From Magic Bullet to Antibody-drug Conjugate (US Version)
Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. However, unlike chemotherapy, ADCs are intended to directly target and kill tumor cells while, at the same time sparing normal, healthy cells. Antibody-drug conjugates…
more -
Highlights from ASH: Conversations about Multiple Myeloma with Thomas Martin and Monica Soni
In December 2022 the annual meeting of the American Society of Hematology took place in the vibrant city of New Orleans and brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from initial hypothesis to…
more -
Mismatched Unrelated Donors: A Key to Erasing the Gap in Donor Availability in HCT
In the 100th episode of the Onco’Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match. In the program today...
-
Susanna Greer, Ph.D.: Advancing Funding for Cutting-edge Cancer Research
In this edition of The Onco'Zine Brief, Peter Hofland, Ph.D, talks with Susanna F. Greer, Ph.D. the Chief Scientific Officer of the V Foundation. In her role, Dr. Greer is a visionary ambassador of the V Foundation, who works with the foundation’s Scientific Advisory Committee to steer funding to...
-
A Novel Approach to Advancing Breast Cancer Therapy
Despite availability of endocrine therapies for advanced or metastatic breast cancer, there remains a critical unmet need for more effective and convenient treatment options that improve both the patient experience and health outcomes. In today’s episode of The Onco’Zine Brief, Peter Hofland…
more -
ESMO 2022: Advances in the Treatment of Cancer
The annual congress of the European Society for Medical oncology or ESMO, is one of the most influential oncology meetings for clinicians, researchers, patient advocates, and healthcare industry representatives from all over the world. This year the annual Congress was held September 9 - 13, 2022...
-
Redefining the Rules of Cancer Treatment
Glioblastoma is an aggressive type of cancer that can occur in the brain or spinal cord. And while the disease can occur at any age, it tends to occur more often in older people. According to the American Cancer Society, United States, doctors diagnose between 12,000 and 14,000 patients with...
-
Valena Wright, MD - It's Time You Knew, The Power of Your Choices to Prevent Women's Cancer
Your annual doctors- (or wellness-) visit may not be enough to prevent diseases like cancer. Daily health and lifestyle choices are the key to cancer prevention - but what are these choices? What is important? In "It’s Time you Knew’ - The Power of Your Choices to Prevent Women's Cancer", board...
-
Lynch Syndrome and Genetic Testing
After checking your cholesterol, hemoglobin A1C, and glucose level during your annual wellness check, your primary care phycisian says: 'It looks like we haven't done your genome. Why don't we do that?' How would you respond? If you have a genetic mutation that increases your risk for a treatable...
-
Marie E. Lamont: Lessons Learned during the COVID-19 Pandemic help in Transforming Patient Access to Clinical Trials
Research out earlier this year confirms what many doctors had feared: Cancer screenings dropped significantly during the Covid-19 pandemic. The study, published in the February 2022 edition of Journal of the National Comprehensive Cancer Network, examined data from the Ontario Cancer Registry in...
-
SABCS 2021: Key Findings in Breast Cancer Research
In the past 30 years, the survival rate for breast cancer has improved by about 40%, one of the highest survival rates of any cancer. The increase in survival is, in part, due to advances in screening technology as well as improvement in cancer treatment and a better understanding of the biology…
more -
Working Tirelessly to Improve the Lives of Cancer Patients
Cancer remains the second leading cause of death in the world, and numbers are on the rise. To respond to the growing need for therapeutic solutions, much research is needed. In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Susan Pandya, MD. Pandya is Vice President Clinical...
-
A Novel, First-in-class, Photodynamic Therapy for Patients with CTCL
In this episode of The Onco’Zine Brief Peter Hofland Ph.D. talks with Ellen J. Kim, MD. Kim is the Medical Director of the Dermatology Clinic at the Perelman Center for Advanced Medicine and Professor of Dermatology at the Hospital of the University of Pennsylvania. She is also the Lead Principal...
-
A Promising Treatment Option for Patients Diagnosed with Head-and-neck Cancer
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Eyal Talor, Ph.D., a clinical immunologist with over 25 years of hands-on management experience in clinical research and drug development. Talor joined CEL-SCI in October 1993 and was promoted to Chief Scientific Officer in...
-
PRECEDE: Transforming the Early Detection and Prevention of Pancreatic Cancer
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Diane Simeone, MD, the Committee Chair and Principal Investigator and Executive Committee Chair of the PRECEDE Consortium. Simeone is also the Laura and Isaac Perlmutter Professor of Surgery, Department of Surgery at NYU...
-
Advancements in the Treatment of Glioblastoma: "More Drug is Not Always Better"
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Nader Sanai, MD. Dr. Sanai is the director of the Ivy Brain Tumor Center and the director of neurosurgical oncology at the Barrow Neurological Institute in Phoenix, Arizona. In this episode of the program Hofland asked Sanai...
-
Antibody-drug Conjugates: Coming of Age
In this episode of The Onco’Zine Brief, developed in collaboration with ADC Review | Journal of Antibody-drug Conjugates (at www.ADCReview.com), Peter Hofland, Ph.D. talks with William (Bill) Newell, JD, Chief Executive Officer and a member of the Board of Directors of Sutro Biopharma...
-
Harnessing the Immune System to Fight Cancer: An Interview with Innate Pharma's Mondher Mahjoubi, MD.
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D., talks with Mondher Mahjoubi, MD, Chief Executive Officer and Chairman of the Executive Board of Innate Pharma, a clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through...
-
Shaping the Possibilities for Patients Everywhere: A Conversation with Zymeworks' Tony Polverino, PhD
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D talks with Tony Polverino, PhD. In September 2918 Polverino joined Zymeworks, a clinical-stage, biopharmaceutical company developing next-generation multifunctional biotherapeutics. He currently serves as the company's Executive Vice...
-
A New Way to Prevent Colon Cancer: A Conversation with Check-Cap's Yoav Kimchy, Ph.D.
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Yoav Kimchy, Ph.D. Kimchy has more than 20 years of experience in the development and management of innovative medical device companies. He founded Check-Cap in 2005 and served as the company's Chief Technology Officer....
-
Advancing the Diagnosis and Treatment of Ductal Carcinoma in Situ (DCIS)
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Leonard Farber, MD, a board-certified Radiation Oncologist, and healthcare executive. Farber is recognized for his ability to identify ground-breaking technologies and position them for success in clinical practice. He…
more -
Increasing Awareness of Colorectal Cancer: Changing Colonoscopy Prep
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Dr. William R. Stern, M.D., a board-certified gastroenterologist and Fellow of the American College of Gastroenterology, at the Capital Digestive Care group outside of Washington, DC, about advancements in colorectal cancer...
-
A Bold Approach in the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talk with Ajay Nooka, MD, MPH, FACP, Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, and Suzanne Trudel, MSc, MD, Associate Professor in the Department of...
-
Developing Transformative Therapies for Patients with Diffuse Large B-cell Lymphoma
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Malte Peters, MD, Chief Research and Development Officer at MorphoSys, and Peter Langmuir, MD., Vice President, Oncology Drug Development at Incyte. In our program today, which was originally recorded in August 2020, Hofland,...
-
Richard Schilsky, M.D. - A Deep Passion for Cancer Medicine
In this episode of The Onco’Zine Brief Peter Hofland talks with Richard Schilsky, M.D. Dr. Schilsky, the Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO), is an oncologist who specializes in new drug development and treatment of…
more -
Pascal Touchon: A Mission to Transform the Lives of Patients with Serious Medical Conditions
In this episode of The Onco’Zine Brief Peter Hofland talks with Pascal Touchon, President, Chief Executive Officer, and member of the Board of Directors Atara Biotherapeutics. With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon has committed his career to...
-
Accelerate the Development of Precision Medicine Diagnostics
In this edition of The Onco’Zine Brief Peter Hofland talks with Peter Keeling about Personalized Medicine, diagnostic testing, and the effect of Covid-19 on cancer and cancer diagnostics. Hofland and Keeling also talk about the world’s first Diagnostic Network for Precision Medicine. Peter…
more -
The Burden of Chemotherapy-induced Myelosuppression
In this episode of The Onco’Zine Brief Peter Hofland Ph.D., talks with Raj Malik M.D. and Robert Epstein M.D. Malik is Chief Medical Officer and Senior Vice President, R&D, at G1 Therapeutics. He leads the company’s clinical development, medical affairs, regulatory affairs, biometrics,...
-
Antibody-dye Conjugates – A Targeted Light Activated Anti-Cancer Treatment
In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at Rakuten Medical.* Rakuten Medical is developing a technology platform called Illuminox™ which is based on a cancer therapy called Near Infrared Photoimmunotherapy. This...
-
C3 – Looking for Ideas Beyond Medicine to Change Cancer Care
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Anthony Yanni, M.D., Senior Vice President, patient-centricity at Astellas. In this role, Yanni is responsible for leading the development and execution of Astellas’ global patient-centricity strategy. To understand patient...
-
A Non-Invasive Blood Test Designed to Advance Infectious Disease Diagnostics
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D., talks with Tim Blauwkamp, Ph.D., Chief Scientific Officer and co-founder of Karius. Karius, based in Redwood City, CA, has developed a non-invasive liquid biopsy, a blood test, called the Karius Test®. The test is based on…
more -
Diagnosed with a Rare Cancer During the COVID-19 Pandemic? What Now?
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talks with Vince McRuiz and Margo Shoup, MD, FACS. Margo Shoup is a nationally recognized surgical oncologist who specializes in gastrointestinal cancers and sarcomas. She is also the senior vice president, and system chair of the...
-
Transforming Cell Therapy Manufacturing by “Squeezing” Cells: An Interview with Armon Sharei
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Armon Sharei, Ph.D. Chief Executive Officer of SQZ Biotech, about the development and manufacturing of cell therapies. Traditionally, the foundation of cancer treatment included surgery, chemotherapy, and radiation therapy.…
more -
ASCO 2020: New Developments in the Treatment of Hard to Treat Cancers
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Christian Massacesi, MD, Senior Vice President, Head of Late Development Oncology R&D at AstraZeneca and with Jeffrey Skolnik, MD, Vice President, Clinical Development at Inovio Pharmaceuticals about new data and exciting...
-
Advancing CAR T-cell Therapy in Difficult to Treat Cancers: An Interview with Precigen’s Helen Sabzevari
In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a biopharmaceutical company dedicated to the discovery and clinical-stage development of the next generation of gene and cell therapies using precision technology. The…
more -
Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC
In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks...
-
Finding Community After a Cancer Diagnosis: A Conversation with Terri Conneran
Struggling in the heat and humidity of the summer of 2016, Terri Conneran believed that her asthma was uncontrolled. In August that year, her physician assistant prescribed her a preventive inhaler. That autumn brought the excuse of allergies, plus time for the new inhaler to take effect. By...
-
Susan Rafte: A 25+ Year Survivor of Metastatic Breast Cancer and Patient Advocate
In this episode The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with Susan Rafte, a 25+ year survivor of metastatic breast cancer and patient advocate. In 1994, eight and a half months...
-
Candid Conversations on Mets, Sex, and Side Effects: a Panel Discussion With Breast Cancer Oncologists, Women’s Health Experts and Patients
In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 - 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life...
-
Catherine Ivy: A Tireless Advocate for Brain Cancer Patients
In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma…
more -
TARDIS - A Simple Blood Draw to Determining a Patient’s Response to Neoadjuvant Therapy
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor,...
-
How does Checkpoint Inhibitor Therapy Work when there’s no Checkpoint Expressed on a Patient's Cancer
Today in The Onco’Zine Brief Peter Hofland talks with Dr. Michael Caligiuri, President of City of Hope National Medical Center in Los Angeles, California and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, and Dr. Jianhua Yu, professor in the Department of Hematology &...
-
BCAN's Mission to Increase Public Awareness, Advance Bladder Cancer Research and Support Patients
Today in The Onco’Zine Brief Peter Hofland talks with Diane Zipursky Quale. Together with her late husband John Quale, Diane, who holds a BA from Stanford University and a JD from the National Law Center, George Washington University, is Co-Founder and Director of the Bladder Cancer Advocacy...
-
Finding Aswers and Improving Patient Care - How Genetic Tests can be Helpful (Part 2)
In this edition of The Onco’Zine Brief Peter Hofland talks with Laura Panos Smith, a certified genetic counselor and vice president of commercial operations at Ambry Genetics. Ms. Smith leads a large team responsible for the implementation of key strategic initiatives for Ambry Genetics. This...
-
Finding Aswers and Improving Patient Care - How Genetic Tests can be Helpful (Part 1)
In this edition of The Onco’Zine Brief Peter Hofland talks with Holly LaDuca, a certified genetic counselor and manager of clinical Research oncology at Ambry Genetics. Identifying an individual’s genetic information is nothing new. And while, over the last decades, most people have become…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
HOSTED BY
Peter Hofland
Loading similar podcasts...
Frequently Asked Questions
How many episodes does The Onco'Zine Brief have?
The Onco'Zine Brief currently has 107 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is The Onco'Zine Brief about?
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for...
How often does The Onco'Zine Brief release new episodes?
The Onco'Zine Brief publishes regularly with 107 episodes available. Check the episode list for the typical release schedule.
Where can I listen to The Onco'Zine Brief?
You can listen to The Onco'Zine Brief on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts The Onco'Zine Brief?
The Onco'Zine Brief is created and hosted by Peter Hofland.
URL copied to clipboard!